An unexpected "storm"
Release time:
2020-07-22
An unexpected "storm"
2018 10# July 18 Early in the morning, I received a phone call from manager Zhou of the quality department of a major customer company, saying that the HYA53 cable produced by our company was sent to a well-known testing organization in Shanghai for testing, and many indicators of the product failed. Hearing the news, I was like a thunderbolt. For so many years, there has never been a third-party failure test for local telephone cables. Is the quality of our products really so poor this time? If it is true, then where is the reputation of our company, where is the integrity, and will customers still exist?
After the tension, I immediately asked what indicator was unqualified. The customer then sent me the unqualified items. I quickly looked at them and found that among the nearly 20 indicators, there were four unqualified indicators: resistance, capacitance, attenuation and near string. I immediately went to check the production and inspection records, and also asked the employees in charge of production and inspection. The records showed that the product indexes were qualified and the indexes were relatively large, and there was no abnormal situation in the production process. Resistance, capacitance and attenuation are all related to length. I immediately realized that this sample may be a problem with the test length.
So I asked the relevant personnel if there was any length deviation. The operator reflected that because he knew that this cable was a sample for testing, more than 2 meters were reserved at the inner and outer ends for testing the length of the wiring, and the length was written as 100 meters according to the customer's requirements. Therefore, the actual length of the cable should be about 105 meters. I immediately contacted the personnel of the testing organization and asked her to help check whether there was any length deviation. The next day I got a reply, the actual length is 105-107 meters, and the testing organization tests according to 100 meters on the certificate. The
detection mechanism said that the resistance and capacitance indexes were qualified after conversion by length, but the attenuation and near string indexes were still unqualified after conversion by length. I wondered, not knowing how to explain, and asked for the cable to be retested, but was refused. So I asked the testing agency to send me the original data of the test. The testing agency did not agree with my request. They said that there was no practice of retesting unqualified products, and there was no precedent for sending the original data to customers.
The testing agency does not agree to retest. There are only two options before us: one is to re-produce a cable to test and help the customer get a qualified test report; The second is to analyze the test data of the product to see if the test is wrong. If there is a mistake, we can appeal. For our customers, there is no doubt that the first choice is the best. We can get the test report as soon as possible and have an explanation. It is undoubtedly very difficult for the testing organization to provide the original data. However, our general manager Li didn't think so after knowing the situation. He said that if we send the products for inspection again, the inspection fee of more than 10,000 yuan is a trivial matter. The key is that customers will think that we are not qualified even in the sample line, so the products we supply them must be junk products at ordinary times. We will be regarded as dishonest suppliers, and problems may occur in future cooperation, losing our most important customer right now. Therefore, we must confirm whether our products are really problematic. It is a very important step for testing agencies to provide data. If handled well, it may turn bad things into good things.
was deadlocked for nearly two weeks. The customer was eager to use the test report and asked us to get the qualified report as soon as possible, and some doubts were revealed in the words. The production department rearranged the production of a sample line. The sales department contacted the major customers in Jiangsu and borrowed their authoritative US DCM equipment for testing. The comprehensive management department arranged a special car and I personally sent the products to Jiangsu for testing. One day a back and forth, in exchange for satisfactory full performance qualified test results, which makes us more confident in our products. Using this convincing data, and under the strong request of our customers, the testing organization finally sent us the original data. After getting the data, the relevant personnel of the company held a special meeting to analyze and study the data, and found that the testing organization applied the standard incorrectly and caused the wrong judgment. We wrote the relevant misunderstanding and sent it to the testing agency, and they finally approved our complaint and re-judged the product as qualified. After
, manager Zhou told me in wechat: "you are right. I believe in the quality of your products, because your leaders attach great importance to the quality of products, and your professional level is higher than that of the testing institutions!" I sent her a happy smile. An unexpected storm finally cleared the weather and turned a bad thing into a good thing. At this time, I found the sun is so warm and bright ...... (Lu Chaofang)
More information
2020
11-03
Jinhua Municipal Party Committee Secretary Chen Long: I wish your enterprise better and better
On the morning of October 16, Chen long, secretary of the Jinhua Municipal CPC Committee, and his entourage came to the construction site of Jianfeng Pharmaceutical's internationalization project to investigate and affirmed the good development status and clear future development ideas of Jianfeng Pharmaceutical. At the construction site, Jiang Xiaomeng, chairman of the group company and chairman of the pharmaceutical company, introduced the overall situation of the investment scale, factory layout, and production direction of the Jianfeng Pharmaceutical internationalization project to Chen Long and his entourage. Huang Jinlong, general manager of the pharmaceutical company, accompanied Chen Long and his entourage to visit the preparation workshop under construction. The construction site is neat, tidy and orderly, and the facilities and equipment are perfect and advanced, all have been unanimously affirmed by the leaders who came to investigate. When learning that the peak internationalization project has introduced international advanced equipment, built in accordance with European and American standards, and its products are oriented to the international market, Chen long said happily: "your goals are very clear and your thinking is very clear. I wish your enterprise better and better!" (this newspaper reporter)
2020
10-23
Liu Haiping, vice mayor of Pu'er City, said during the survey: "Peak is an enterprise with feelings"
On September 30, Liu Haiping, member of the standing Committee of the Pu'er Municipal CPC Committee and vice mayor of Pu'er City, Yunnan Province, and relevant responsible persons of Pu'er City and Simao District, visited the company for investigation and research, and communicated with the leaders of the group company on topics such as further strengthening cooperation between the two sides. "Yunnan Jianfeng has not only developed well in Pu'er these years, achieved good benefits and contributed considerable tax revenue, but also made great contributions to promoting the economic development of Pu'er and the stability of the southwest border region. It is our 'star enterprise' and 'baby enterprise '." Liu Haiping said so in the exchange. He said that Pu'er is an important window for the implementation of the "Belt and Road" concept. It has good conditions in natural resources, transportation, electricity, etc., and the peak is a "sentimental enterprise" and has a good foundation in the local area. Strengthen cooperation; various government departments will also earnestly "stand on the platform" and "do a good job as a shopkeeper" to serve enterprises. Chairman Jiang Xiaomeng and General Manager Yu Jianhong exchanged views with Liu Haiping and his party on the layout of peak industry and strengthening cooperation with Pu 'er. After that, accompanied by General Manager Yu Jianhong and Deputy General Manager Huang Jinlong, Liu Haiping and his party visited the Jinxi Factory of Jianfeng Pharmaceutical Factory. (this newspaper reporter)
2020
10-09
The first batch of Jianfeng Pharmaceuticals to enter Jinhua (Shanghai) Science and Technology Center
News from our newspaper On September 16, at the unveiling ceremony of the Yangtze River Delta G60 Jinhua (Shanghai) Science and Technology Innovation Center and Jinhua (Shanghai) Talent Building, Jiang Xiaomeng, chairman of the group company and chairman of the pharmaceutical company, took over from Chen Long, secretary of the Jinhua Municipal Party Committee. The golden key with big red flowers. Spike Pharmaceuticals became one of the first seven companies to enter the center. The Yangtze River Delta G60 Jinhua (Shanghai) Science and Technology Center and Jinhua (Shanghai) Talent Building are the first "Science and Technology and Talent Enclave" in Shanghai in the nine cities of the Yangtze River Delta G60 Science and Technology Corridor, and the first cross-regional industrial collaborative innovation center in the Science and Technology Corridor. The center is located in Shanghai Lingang Songjiang Science and Technology City, with a total area of nearly 10,000 square meters. It includes two parts: science and technology innovation and talent service. There are five major centers, including talent service center, science and technology innovation exhibition center, business incubation center, enterprise research and development center, and talent project roadshow center. It is a science and technology innovation platform that integrates the functions of project incubation, recruitment of institutions, and talent recruitment. Chen Long, secretary of the Jinhua Municipal Party Committee, said in his speech at the unveiling ceremony that in the future, all scientific and technological enterprises stationed in Jinhua (Shanghai) Science and Technology Center and Talent Building can equally enjoy Jinhua's local science and technology and talent policies, so as to further break the space limitation, enable talents from the two places to share the most favorable treatment and convenient services, help enterprises to develop in Shanghai and achieve industrialization in Jinhua. At the ceremony, leaders such as Chen Long, secretary of the Jinhua Municipal Party Committee, and Cheng Xiangmin, secretary of the Shanghai Songjiang District Party Committee, awarded seven companies, including Jianfeng Pharmaceutical, the golden key to symbolize their entry. At the Yangtze River Delta Integrated Talent Cooperation Project Symposium held after the ceremony, Jiang Xiaomeng spoke as a representative of Jinhua entrepreneurs. He believed that Shanghai, as an international metropolis, has an agglomeration effect on high-end intellectual resources and grasps the first-class element resources of scientific and technological innovation in China and even the world. The establishment of G60 Jinhua (Shanghai) science and technology innovation center and talent building in the Yangtze River Delta helps Jinhua enterprises to take off in scientific and technological innovation and information exchange, which will provide strong and continuous scientific and technological support and intellectual support for the long-term development of enterprises in the future, and attract more excellent domestic and foreign talents to serve Jinhua enterprises, It plays a key role in further improving scientific research ability, innovation ability and personnel training. During the event, Jiang Xiaomeng successively accepted on-site interviews with "People's Daily", "Liberation Daily", "Zhejiang Daily" and other media. He said that the establishment of science and technology innovation and talent bases in Shanghai has greatly enhanced Jinhua's attractiveness to enterprises. "With this base, we don't need to introduce talents to Jinhua, but directly recruit talents in Shanghai, and at the same time enjoy Jinhua's various talent recruitment policies, and change Shanghai talents to Jinhua's use. This is a kind of bold. The innovation has greatly solved the dilemma of attracting talents for enterprises." As a settled enterprise, it will also make full use of its own advantages to continuously inject resource vitality into the science and technology innovation center, and continue to contribute to the long-term development of Jinhua's economy. (this newspaper reporter)
2020
09-22
Spike Pharmaceutical Added New Products
On September 3, Spike Pharmaceutical Company received the approval of the State Drug Administration for the registration of esomeprazole sodium for injection (approval number: 2020S00572). Esomeprazole sodium for injection is mainly used to treat low-risk patients with gastroesophageal reflux disease and acute gastric or duodenal ulcer bleeding when oral therapy is not applicable. It has been listed in the National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug List (2017 Edition) ", classified as Class B. According to industry statistics, 30 companies including Zhengda Tianqing and Qilu Pharmaceutical have been approved for listing in China. In 2019, domestic sales (including urban and county-level public hospitals, community and township health centers) were about 3.317 billion yuan. Jianfeng Pharmaceutical submitted an application for registration of esomeprazole sodium for injection to the State Food and Drug Administration in November 2013 and was accepted. Up to now, Jianfeng Pharmaceutical has invested nearly 15 million yuan in research and development for the project and has a corresponding production line. This time to obtain the injection of esomeprazole sodium drug registration approval, marking the peak pharmaceutical has the drug production, sales qualification, will further enrich the peak pharmaceutical product line, help to enhance the competitiveness of the peak pharmaceutical business. (Lu Yating, Liu Yang)
2020
09-11